Prognostic Role of Diastolic Left Ventricular Mechanical Dyssynchrony by Gated Single Photon Emission Computed

Le Ngoc Ha1, Nguyen Thi Thanh Trung2, Mai Hong Son1

  • 1Department of Nuclear Medicine, Hospital 108, Hanoi, Vietnam.

Insights

Diastolic mechanical dyssynchrony (LVMD) measured by gated-SPECT myocardial perfusion imaging predicts major adverse cardiac events in post-myocardial infarction patients. These findings highlight LVMD parameters as crucial prognostic indicators.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • Myocardial infarction (MI) survivors face risks of major adverse cardiac events (MACE).
  • Assessing prognosis in post-MI patients is crucial for guiding treatment strategies.
  • Left ventricular mechanical dyssynchrony (LVMD) may impact cardiac function and outcomes.

Purpose of the Study:

  • To evaluate the prognostic value of diastolic LVMD using gated-single photon emission computed tomography (GSPECT) myocardial perfusion imaging (MPI).
  • To determine if LVMD parameters can predict MACE in patients after MI.

Main Methods:

  • 106 post-MI patients were analyzed using GSPECT MPI.
  • Diastolic LVMD indices, including phase standard deviation (PSD) and histogram bandwidth (HBW), were measured.
  • Patients were followed for MACE, with prognostic value assessed via ROC and survival analyses.

Main Results:

  • Specific cut-off values for PSD (55.5°) and HBW (174.5°) showed significant sensitivity and specificity in predicting MACE.
  • Significant differences in time to MACE were observed between patient groups based on PSD levels.
  • PSD, HBW, and left ventricle ejection fraction (LVEF) from GSPECT were significant predictors of MACE.

Conclusions:

  • Diastolic LVMD parameters (PSD and HBW) derived from GSPECT MPI are significant prognostic factors.
  • These parameters aid in predicting MACE in patients post-MI.
  • GSPECT MPI offers valuable insights into diastolic dyssynchrony for risk stratification.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
26
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17